Skip to main content

Table 1 Clinical characteristics, hormonal and biochemical results of the study groups

From: The role of ERK-1 and ERK-2 gene polymorphisms in PCOS pathogenesis

Variables

PCOS (n = 102)

Control (n = 102)

p-value

Age (years)

30.88 ± 8.36

30.68 ± 4,36

0.07

BMI (kg/m2)

29.02 ± 5.64

26.55 ± 6.07

p ≤ 0.001

WHR

0.78 ± 0.22

0,71 ± 0.14

0.006

Ferriman Gallwey Score (FGS)

12.43 ± 5.80

5.88 ± 2.06

p ≤ 0.001

HOMA-IR

2.92 ± 1.89

1.78 ± 0.97

p ≤ 0.001

CRP

11.67 ± 2.73

6.53 ± 3.85

p ≤ 0.001

LH/FSH ratio

1.30 ± 1.03

0.78 ± 0.56

p ≤ 0.001

Total Testosterone (ng/dl)

0.74 ± 0.36

0.51 ± 0.20

p ≤ 0.001

Triglycerides (mg/dl)

117.85 ± 48.89

91.80 ± 38.09

p ≤ 0.001

Total Cholesterol (mg/dl)

192.21 ± 43.59

169.45 ± 30.12

p ≤ 0.001

LDL (mg/dl)

116.95 ± 41.63

99.50 ± 26.46

p ≤ 0.001

HDL (mg/dl)

51.70 ± 10.45

52.74 ± 11.54

0.848

  1. Data presented as Mean ± SD
  2. P < 0.05 accepted as  statistically significant